Results 141 to 150 of about 2,693 (166)

Cilastatin/imipenem/relebactam

Reactions Weekly, 2022
openaire   +1 more source

Biomerieux Imipenem Relebactam IVD

Biomedical Safety & Standards, 2021
openaire   +1 more source

Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

Clinical Infectious Diseases, 2022
Ryan K Shields, Madison E Stellfox, Ellen G Kline   +2 more
exaly  

Synthesis of β-Lactamase Inhibitor Relebactam

Synfacts, 2020
openaire   +1 more source

Imipenem–Cilastatin Sodium–Relebactam

2021
openaire   +1 more source

Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants

Antimicrobial Agents and Chemotherapy, 2020
Pablo A Fraile-Ribot, Laura Zamorano, Ester Del Barrio-Tofiño   +2 more
exaly  

Imipenem/cilastatina/relebactam en infecciones por bacterias gramnegativas

Panorama Actual del Medicamento
Relebactam es un nuevo inhibidor de betalactamasas con estructura no betalactámica, con capacidad para inhibir betalactamasas de tipo A y C, pero no B y D. Sin actividad antibacteriana significativa, la función de relebactam en la combinación con imipenem y cilastatina consiste en restituir la actividad bactericida de imipenem cuando ésta se ve ...
openaire   +1 more source

Cilastatin/imipenem/relebactam

Reactions Weekly
openaire   +2 more sources

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

International Journal of Antimicrobial Agents, 2023
Isaac Alonso-García, Adrian Conde, Soraya Rumbo-Feal   +2 more
exaly  

Relebactam. Beta-lactamase inhibitor

Drugs of the Future, 2015
openaire   +1 more source